Ningbo No.2 Hospital
Clinical trials sponsored by Ningbo No.2 Hospital, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New study aims to perfect heart pacing lead placement Results expected Jun 2027 (estimated)
-
Can an immune booster keep liver cancer away after surgery?
Disease control Not yet recruitingThis early-phase study will test whether adding peginterferon alfa-2b to standard antiviral drugs can help prevent hepatitis B-related liver cancer from coming back after surgery. About 156 adults aged 18 to 65 will receive either the combination or antivirals alone. Researchers …
Early phase 1 • Sponsor: Ningbo No.2 Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New study aims to perfect heart pacing lead placement
Disease control Not yet recruitingThis trial tests two different heart pacing leads—one without a hollow core (lumenless) and one with a stylet—to see which works better for left bundle branch pacing. About 288 people with slow heart rhythms will take part. Doctors will use continuous monitoring to guide the lead…
Sponsor: Ningbo No.2 Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC